Intrahippocampal allopregnanolone decreases voluntary chronic alcohol consumption in non-selected rats.
We have recently shown that 0.2 microg of the neurosteroid allopregnanolone (AlloP) administered to the hippocampus induced an anxiolytic-like profile and also reduced alcohol withdrawal symptoms in voluntary and chronic alcohol-drinking rats. The aim of the present work was to study whether the administration of this dose of AlloP could affect alcohol consumption in non-selected rats that have been voluntarily ingesting high doses of alcohol for long periods of time in a limited access procedure. We used a free-choice drinking procedure that involved providing the rats with an alcoholic solution (10% ethanol) at an early age. Alcohol and control rats were assigned randomly to three groups that received an intrahippocampal (dorsal CA1) injection before the period of alcohol consumption after a long history of chronic alcohol intake. The injection groups were AlloP (0.2 microg, 1.26 microM), pregnenolone sulfate (PregS) (5 ng, 24 microM) or vehicle. Blood alcohol concentrations (BAC) were assessed before testing the effects of injections on alcohol consumption. Although AlloP did not eliminate alcohol ingestion, it significantly decreased alcohol consumption. The intrahippocampal administration of PregS, at the dose tested, did not effectively modify alcohol consumption levels. These results indicate that the positive modulation of hippocampal GABA(A) receptors induced by neurosteroids can be an important neurobiological target for reducing chronic alcohol consumption.
Martin-García
Elena
E
Institut de Neurociències, Departament de Psicobiologia i Metodologia de les Ciències de la Salut, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain.
Darbra
Sònia
S
Pallarès
Marc
M
D000428:Alcohol Drinking / Q000188:drug therapy*; D000438:Alcohols / Q000008:administration & dosage / Q000097:blood; D000777:Anesthetics / Q000008:administration & dosage*; D000818:Animals; D001522:Behavior, Animal; D002755:Choice Behavior / Q000187:drug effects; D003216:Conditioning, Operant / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004327:Drinking Behavior / Q000187:drug effects; D005508:Food Deprivation; D005947:Glucose / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology; D016014:Linear Models; D008297:Male; D011280:Pregnanolone / Q000008:administration & dosage*; D011284:Pregnenolone / Q000008:administration & dosage; D051381:Rats; D017208:Rats, Wistar
D000438:Alcohols; D000777:Anesthetics; C018370:pregnenolone sulfate; D011284:Pregnenolone; D011280:Pregnanolone; D005947:Glucose